← All organizations

Vall d'Hebron Institute of Research, Galatea Clinic

Academic/Hospital

Also known as: David Garcia-Dorado | Department of HPB Surgery and Transplants, Hospital Universitario Vall d´Hebron | Department of Oncology, Hospital Universitario Vall d´Hebron | Francesc Bosch, MD | Hospital Universitario Vall d´Hebron | HOSPITAL UNIVERSITARIO VALL D´HEBRON, UNIVERSIDAD AUTONOMA, BARCELONA | HOSPITAL UNIVERSITARIO VALL D´HEBRON, UNIVERSIDAD AUTONOMA DE BARCELONA | Hospital Universitari Vall d'Hebron, Barcelona | IOB Institute of Oncology, Vall d´Hebron Institute of Oncology (VHIO) | Liver Unit, Department of Internal Medicine, Hospital Universitario Vall d´Hebron | Medical Oncology Department, Vall d'Hebron Institute of Oncology, CIBERONC | Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d'Hebron Barcelona Hospital Campus | University Hospital of Vall d'Hebron | Vall de Hebron, Barcelona, Spain | Vall d'Hebron Institut de Recerca (VHIR) | Vall d'Hebron institute of oncology (VHIO), Catalan institute of oncology (Hospitalet) (ICO) | Vall d'Hebron Institute of Research, Galatea Clinic | Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain | Vall d'Hebron University Hospital (HUVH) | VHIO (Vall d'Hebron Institute of Oncology)

Highest phase reached

Phase 4

First clinical trial

Jul 1, 2007

Last known activity

Sep 13, 2024

Timeline

1990s

  1. Jan 1, 1994

    Vall d'Hebron Institute of Research, Galatea Clinic— Founded

Drugs by trial phase (34 distinct, 16 trials)

Phase 4 (4 own, 0 via acquisition)

Phase 3 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

Indications

Recent trials (17)

Details

Founded
Barcelona, ES Jan 1, 1994
Last known activity
Sep 13, 2024